The report will be delivered in 2-3 business days.

Cervical Cancer Diagnostics Market Global Report 2020-30: Covid 19 Growth and Change

Starting Price : $ 4000.00 | Pages : 150 | Published : August 2020 | SKU CODE : 7656 | Format :


The cervical cancer diagnostics market consists of sales of cervical cancer diagnostic devices and related services by entities (organizations, sole traders and partnerships) that produce cervical cancer diagnostics devices. Cervical cancer is a type of cancer that occurs in cells of the cervix. These devices are used for the diagnosis of cervical cancer.

The global cervical cancer diagnostics market is expected to decline from $8.02 billion in 2019 to $7.23 billion in 2020 at a compound annual growth rate (CAGR) of -9.87%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, especially postponement of non-emergency procedures. The market is then expected to recover and reach $8.62 billion in 2023 at a CAGR of 6.04%.

North America was the largest region in the cervical cancer diagnostics market in 2019.

The rising adoption of cervical cancer diagnostic tests for the early detection of cervical cancer is expected to drive the market for cervical cancer diagnostics. Increasing awareness among women about cervical cancer along with the emphasis by worldwide cancer organizations and governments on early testing for detecting cervical cancer and preventing it contributes to the growth of the market. For instance, in August 2018, the United States Preventive Services Task Force has updated its screening guidelines for cervical cancer, which specifies that women between ages 21 to 29 should be screened with a Pap test every 3 years, women between ages 30 to 65 should be screened with any of three tests, namely high-risk HPV testing alone, Pap and high-risk HPV contesting for every 5 years and Pap test alone for every 3 years. The rising adoption of cervical cancer diagnostic tests and emphasis on early diagnosis propels the market.

The increased use of HPV vaccination is anticipated to hinder the cervical cancer diagnostics market. According to the World Health Organization, the 2 HPV types (16 and 18) cause 70% of cervical cancers and pre-cancerous cervical lesions, thereby giving human papillomavirus (HPV) vaccine is effectively reducing the numbers of cervical pre-cancerous lesions that may develop into cervical cancers. The study published in Cancer Epidemiology, Biomarkers & Prevention, in February 2019 supported the information from the Centers for Disease Control and Prevention (CDC) that states that among women who had been vaccinated, the share of precancers caused by HPV 16 and 18 dropped from 55.2% to 33.3% whereas, in unvaccinated women, the proportion dropped from 51% to 47.3%. The HPV vaccine is recommended by the Centers for Disease Control and Prevention (CDC) for all the kids and adults between the ages of 9 to 26. Therefore, the increased use of HPV vaccination is predicted to hinder the cervical cancer diagnostics market.

The increased adoption of HPV home testing kits is expected to be the new trend in the market. The home-based HPV testing kits help women in collecting samples and getting the results conveniently on their own without going to the lab for screening. Therefore, companies are focusing on providing convenience to patients. For instance, in January 2019, Nurx, a consumer health and telemedicine company, introduced lab testing that allows women to easily and affordably monitor their risk of cervical cancer from the comfort of their home. Similarly, in April 2019, Matter introduced three conceptual cervical cancer examinations through the Sukha project that help women carry out tests at home to break the stigma associated with cervical testing.

In November 2018, QIAGEN, a German-based leading supplier of specimen and assay systems for diagnostic techniques, applied testing, academic and pharmaceutical research, collaborated with Self-screen BV and released the QIAscreen HPV PCR Test, a CE-IVD molecular diagnostic test for the detection of 15 recognized high-risk human papillomavirus (HPV) genotypes, which is considered to be the cause of cervical cancer. Self-screen BV is a VU University Medical Centre’s spinoff company based in the Netherlands.

The major players covered in the cervical cancer diagnostics market report are Abbott Laboratories, Becton, Dickinson and Co., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Hologic Inc., QIAGEN NV, Quest Diagnostics Inc., Siemens Healthineers AG, Zilico, Guided Therapeutics.

The countries covered in the cervical cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The regions covered in the cervical cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

1) By Diagnostic Test: Pap Smear Test, HPV Test, Colposcopy, Biopsy and Endocervical Curettage, Other Diagnostic Tests 2) By End User: Hospitals, Specialty Clinics, Cancer and Radiation Therapy Centres, Diagnostic Centres

    1. Executive Summary

    2. Cervical Cancer Diagnostics Market Characteristics

    3. Cervical Cancer Diagnostics Market Size And Growth

    3.1. Global Cervical Cancer Diagnostics Historic Market, 2015 - 2019, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Cervical Cancer Diagnostics Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Cervical Cancer Diagnostics Market Segmentation

    4.1. Global Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Pap Smear Test

    HPV Test

    Colposcopy

    Biopsy and Endocervical Curettage

    Other Diagnostic Tests

    4.2. Global Cervical Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    Hospitals

    Specialty Clinics

    Cancer and Radiation Therapy Centres

    Diagnostic Centres

    5. Cervical Cancer Diagnostics Market Regional And Country Analysis

    5.1. Global Cervical Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    5.2. Global Cervical Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Cervical Cancer Diagnostics Market

    6.1. Asia-Pacific Cervical Cancer Diagnostics Market Overview

    6.2. Asia-Pacific Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    7. China Cervical Cancer Diagnostics Market

    7.1. China Cervical Cancer Diagnostics Market Overview

    7.2. China Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

    8. India Cervical Cancer Diagnostics Market

    8.1. India Cervical Cancer Diagnostics Market Overview

    8.2. India Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    9. Japan Cervical Cancer Diagnostics Market

    9.1. Japan Cervical Cancer Diagnostics Market Overview

    9.2. Japan Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    10. Australia Cervical Cancer Diagnostics Market

    10.1. Australia Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    11. Indonesia Cervical Cancer Diagnostics Market

    11.1. Indonesia Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    12. South Korea Cervical Cancer Diagnostics Market

    12.1. South Korea Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    13. Western Europe Cervical Cancer Diagnostics Market

    13.1. Western Europe Cervical Cancer Diagnostics Market Overview

    13.2. Western Europe Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    14. UK Cervical Cancer Diagnostics Market

    14.1. UK Cervical Cancer Diagnostics Market Overview

    14.2. UK Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    15. Germany Cervical Cancer Diagnostics Market

    15.1. Germany Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    16. France Cervical Cancer Diagnostics Market

    16.3. France Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    17. Eastern Europe Cervical Cancer Diagnostics Market

    17.1. Eastern Europe Cervical Cancer Diagnostics Market Overview

    17.2. Eastern Europe Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    18. Russia Cervical Cancer Diagnostics Market

    18.1. Russia Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    19. North America Cervical Cancer Diagnostics Market

    19.1. North America Cervical Cancer Diagnostics Market Overview

    19.2. North America Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    20. USA Cervical Cancer Diagnostics Market

    20.1. USA Cervical Cancer Diagnostics Market Overview

    20.2. USA Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    21. South America Cervical Cancer Diagnostics Market

    21.1. South America Cervical Cancer Diagnostics Market Overview

    21.2. South America Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    22. Brazil Cervical Cancer Diagnostics Market

    22.1. Brazil Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    23. Middle East Cervical Cancer Diagnostics Market

    23.1. Middle East Cervical Cancer Diagnostics Market Overview

    23.2. Middle East Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    24. Africa Cervical Cancer Diagnostics Market

    24.1. Africa Cervical Cancer Diagnostics Market Overview

    24.2. Africa Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

    25. Cervical Cancer Diagnostics Market Competitive Landscape And Company Profiles

    25.1. Cervical Cancer Diagnostics Market Competitive Landscape

    25.2. Cervical Cancer Diagnostics Market Company Profiles

    25.2.1. Abbott Laboratories

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Becton, Dickinson and Co.

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Bio-Rad Laboratories Inc.

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. F. Hoffmann-La Roche Ltd.

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Hologic Inc.

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Cervical Cancer Diagnostics Market

    27. Cervical Cancer Diagnostics Market Trends And Strategies

    28. Cervical Cancer Diagnostics Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Table 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 3: Global Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 4: Global Cervical Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 5: Global Cervical Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 6: Global Cervical Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 7: Asia-Pacific, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 8: China, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 9: India, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 10: Japan, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 11: Australia, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 12: Indonesia, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 13: South Korea, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 14: Western Europe, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 15: UK, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 16: Germany, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 17: France, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 18: Eastern Europe, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 19: Russia, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 20: North America, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 21: USA, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 22: South America, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 23: Brazil, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 24: Middle East, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 25: Africa, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Table 26: Abbott Laboratories Financial Performance
  • Table 27: Becton, Dickinson and Co. Financial Performance
  • Table 28: Bio-Rad Laboratories Inc. Financial Performance
  • Table 29: F. Hoffmann-La Roche Ltd. Financial Performance
  • Table 30: Hologic Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2019, $ Billion
  • Figure 2: Global Forecast Market Growth, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 3: Global Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 4: Global Cervical Cancer Diagnostics Market, Segmentation By End User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 5: Global Cervical Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 6: Global Cervical Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 7: Asia-Pacific, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 8: China, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 9: India, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 10: Japan, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 11: Australia, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 12: Indonesia, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 13: South Korea, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 14: Western Europe, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 15: UK, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 16: Germany, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 17: France, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 18: Eastern Europe, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 19: Russia, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 20: North America, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 21: USA, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 22: South America, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 23: Brazil, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 24: Middle East, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 25: Africa, Cervical Cancer Diagnostics Market, Segmentation By Diagnostic Test, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Figure 26: Abbott Laboratories Financial Performance
  • Figure 27: Becton, Dickinson and Co. Financial Performance
  • Figure 28: Bio-Rad Laboratories Inc. Financial Performance
  • Figure 29: F. Hoffmann-La Roche Ltd. Financial Performance
  • Figure 30: Hologic Inc. Financial Performance
Development Of Alternative Products In The Blood Glucose Test Strips Market- Silk Strips, Continuous Test Tapes
The Refractive Surgery Devices And Equipment Industry Will Reach $1.18 Billion By 2022
High Risk Of Diabetic Patients Suffering From The Coronavirus Has Led To Increased Demand For POC HbA1C Testing
Increasing Adoption Of Neurological Devices Over Drug Therapies
Resmed And General Electric Company- Leaders In The Anesthesia And Respiratory Devices Market
Increase In Collaborations And Partnerships In The Medical Sensors Market
Smart Inhalers And Wearables For Patients Suffering From Respiratory Diseases
Tobacco Smoking, Sleep Apnea, And Changing Climate Conditions Are Increasing The Demand For Respiratory Devices
Respiratory Devices And Equipment (Diagnostic) Global Market Report 2020-30: Covid 19 Growth and Change
View Report
Methanol Market - By End Use (Formaldehyde, Mto/Mtp, Fuel Blending, Dimethyl Ether, Acetic Acid, Methyl Tert-Butyl Ether (Mtbe), Solvents, Methylamines, Mma, Chloro-Methanes, And Others), By Type Of Product( Plastics & Polymers, Chlor-Alkali And Inorganics, Olefins, Aromatics, Olefin Derivatives, Syngas Chemicals), Market Players, And By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
Respiratory Masks (N95 Respirators, Surgical Masks, And Others) Market - By Type (N95 Respirators, Common Grade Surgical Masks And Non-Medical Grade Respiratory Masks), By End-User (Hospitals And Clinics, Individual, Industrial, And Others), By Distribution Channel (Hospitals, Retail And Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Portable Ultrasound Devices Market - By Segments (Mobile Ultrasound Devices And Handheld Ultrasound Devices), By End User ( Cardiovascular, Obstetrics / Gynecology, Gastro, Musculoskeletal And Point Of Care / Others), And By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
Portable X-Ray Devices Market - By Segments (Mobile X-Ray Devices, Handheld X-Ray Devices), By Types (Computed Radiography X-Ray Devices, Digital X-Ray Devices And Analog X-Ray), And By Region, Opportunities And Strategies – Global Forecast To 2022
View Report
Disposable Hospital Supplies Market Global Report 2020-30: COVID 19 Implications and Growth
View Report
Sterilization Equipment and Disinfectants Market Global Report 2020-30: COVID 19 Implications and Growth
View Report
Nebulizers Market - By Type Of Devices (Pneumatic Nebulizer, Ultrasonic Nebulizer, Mesh Nebulizer), By Application (Copd, Cystic Fibrosis, Asthma, Others), By Portability (Tabletop, Portable), By End-User (Hospitals And Clinics, Emergency Centers, Home Healthcare), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)